2-(azocan-1-yl)-5-[(4-methylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid
C22H26F3N3O6S — CID 146054691
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(azocan-1-yl)-5-[(4-methylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid
2-(azocan-1-yl)-5-[(4-methylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid (PubChem CID 146054691) has the molecular formula C22H26F3N3O6S and a molecular weight of 517.53 g/mol. Its IUPAC name is 2-(azocan-1-yl)-5-[(4-methylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 2-(azocan-1-yl)-5-[(4-methylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 146054691 |
| Molecular Formula | C22H26F3N3O6S |
| Molecular Weight | 517.53 g/mol |
| Exact Mass | 517.15 |
| IUPAC Name | 2-(azocan-1-yl)-5-[(4-methylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid |
| SMILES | Cc1ccc(S(=O)(=O)Nc2cnc(N3CCCCCCC3)c(C(=O)O)c2)cc1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C20H25N3O4S.C2HF3O2/c1-15-7-9-17(10-8-15)28(26,27)22-16-13-18(20(24)25)19(21-14-16)23-11-5-3-2-4-6-12-23;3-2(4,5)1(6)7/h7-10,13-14,22H,2-6,11-12H2,1H3,(H,24,25);(H,6,7) |
| InChIKey | JDXAEDCPWWTKNI-UHFFFAOYSA-N |
| XLogP | 4.29 |
| TPSA | 136.90 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 517.53 |
| LogP ≤ 5 | 4.29 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146054691 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.